Metformin vs Semaglutide for blood sugar
Short answer: For blood sugar, more users report improvement with Metformin — 95% of 20 reports, versus 88% of 8 for Semaglutide.
Metformin has 1,367 meta-analyses and 3,450 randomized trials on PubMed; Semaglutide has 421 and 307.
Based on 157 reports about Metformin and 314 about Semaglutide. Not medical advice.
| Metformin Medication | Semaglutide Medication | |
|---|---|---|
| User score | 43 | 64 |
| Verdict | Mixed | Mostly positive |
| Positive of reports that state an outcome | 29% | 64% |
| Reports | 157 | 314 |
| Research | AResearch: Strong | AResearch: Strong |
| Meta-analyses / RCTs | 1,367 / 3,450 | 421 / 307 |
| Mainly used for | ||
| Weight loss % reporting improvement | 90% (10) | 84% (129) |
| Appetite % reporting improvement | 100% (2) | 83% (64) |
| Focus % reporting improvement | 67% (3) | 60% (5) |
| Energy % reporting improvement | 40% (10) | 39% (23) |
| Sleep % reporting improvement | 100% (2) | 50% (4) |
| Mood % reporting improvement | 50% (2) | 27% (11) |
| Memory % reporting improvement | 100% (2) | — |
| Performance % reporting improvement | 0% (15) | 83% (6) |
| Recovery % reporting improvement | — | 100% (2) |
| Pain & inflammation % reporting improvement | — | 80% (5) |
| Digestion % reporting improvement | 29% (7) | 43% (7) |
| Libido % reporting improvement | — | 0% (3) |
| Hormones % reporting improvement | 40% (5) | 100% (2) |
| Blood sugar % reporting improvement | 95% (20) | 88% (8) |
| Heart & lipids % reporting improvement | — | 100% (3) |
| Skin & hair % reporting improvement | — | 33% (3) |
| Longevity % reporting improvement | 100% (8) | — |
| Common side effects | stomach issues, diarrhea, b12 depletion, nausea | nausea, fatigue, stomach issues, constipation |
| Typical dose reported | 250-1500 mg / daily | 2.4 mg / once weekly |
The choice of metformin or COCP treatment should be based on symptoms, noting some biochemical benefits from combination treatment targeting both major endocrine disturbances seen in PCOS (hyperinsulinemia and hyperandrogenism).
J Clin Endocrinol Metab, 2024 ↗“Metformin currently has enough data for me personally to feel comfortable not only taking it myself (and my wife), but also recommending it to my patients.”
This study shows that new anti-diabetic drugs, particularly GLP1-RA and Tirzepatide, are the most effective in inducing weight loss in patients with type 2 diabetes. Interestingly, exenatide appears to be the only GLP1-RA that induces a mild weight loss.
Pharmacol Res, 2021 ↗“I've lost 35lbs since then and now I'm in the Healthy range on BMI. My IBSD has virtually disappeared.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate